Never looked back..Pal told me about Pizer and the Crede deal. That is all I had to know.
He is involved.. I am involved...Funny I never saw his name mentioned anywhere here and there was no reason to look backward...But thanks for making me look stupid. I deserve it as I am usually more suspect of stocks trading at $1.00
Just watched it...Fabulous. She was a Scripps patient and the moderator mentioned Scripps was the only place in Southern California that did the trial. She was 100 poiunds overweight and she had lost 69 pounds and was still on the device. TYhe doctor was great in describing what happens, but she lost 69 pounds of the 100 she was overweight. That is a lot more than 25% of Excess. Everyone should watch it. And LA is no small market.
Mike Magnant on the website spoke at teh ADCOM and siad he went from 280 to 210. Venture a guess for me.
Some people have been on the device for 36 months. Where do you think their TOTAL weight loss is?
If you read the recent 8K regarding Crede and their consulting agreement with XXII there is one name that pops up.
He is Terren Pizer. I believe he is the party who invested at $2.58 and liquified the company. I know of him from a previous life. He was one of Mile Milken's brightest stars back in the 1980s and he is purported to be a brilliant investor. Having him as a large player in XXII makes me very comfortable. He is leading the charge to Asia ans that is where the magic of XXII will really prove out. This story is 2 quarters behind because of management moves and acquisitions. `See you in September.
You sort of missed some commentary. Their IR/PR firm was working on the media and print stuff from back in early FAll Did you see all the TV and press thery got? That is what engenderd the Webinair. I say they didVBLOC a great job there and that was five months before the FDA came back They brought on an experienced operations guy. They were not asleep at the switch, they just did not communicate much as the FDA was looking at them all the time. Even the Cannacord presentation was exisiting boilerplate with the optimism that approval was coming before year end. They missed by two weeks. Since the ADCOM I believe they filed additional patents. What else were they working on is what we will find out next week. We know they are focused on the 13 Centers of Excellence and now a huge Webinair to start the process. They will disclose the price of the device next week and where they are in the CPT code talks.
I hope they discuss contacts and discussions they are having with third parties rergarding foreign sales which we are not going to do ourselves. The hint that contract salespeople are being recruited makes a great deal of sense and after the webinair we will get a much better feeling of how they are going to train the doctors. Maybe we open a VBLOC University. We are all still guessing on a lot of the potentil news but I am sure they did not waste any time after ADCOM. He told us they were halfway through the 18-24 month CPT discussions with the AMA on the codes. VBLOC is going to be a huge product but as usual I am focused on the science and where they plan to take it next, That is exciting to me.
Sentiment: Strong Buy
I stand corrected. The NASDQ data shows only 4 million shares but the must own warrants. I did not know they owned that much.
It is 8 1/2% of the float...Total outstanding includes warrants and options. My bet is they bought some of the ATM stock from Cowen. T Rowe is in Baltimore and so is Johns Hopkins. T. Rowe is a huge biotech investor and is to me the best research house in the nation.
When they call Knudson, he picks up the phone.
Hey Magilla..I know who you are. You appeared two weeks after they tossed the CEO. You wouldn't be his wife or cousin would you????
Curious..Why do you sit here and break the balls of a stock that trades at $1.00???
Don't you have anything better to do with your life?
They never quoted $2500 per device. Device price is not known?? The Mayo Clinic is obvious clueless? Please do not make comments where your data is flawed.Stop your I Phone comparison. The I Phone sells for $600 and costs $235. I know that because the company said that. We have had no price indications for anything from ETRM and if the device costs $2500 they are nuts. They buy parts from different suppliers you have to believe and have them assembled. But not for $2500.
Go find out what a Pacemaker costs to make. Then come back.
Contract reps are experienced operators who love new products and follow the device business well. They probably contacted the company. And they cost nothing. They are total commission people and in-house usually is a wate of money because the good guys are the contract folks. It is all performance and commissions. They also know all the doctors so they are not blind calling. I like the fact they are coming on board. My knee replacement was from a company called Conformis in Boston. My doc was totally Stryker and he went to Boston, got trained in two days and now he is toally Conformis. A sales rep introduced him to it. Conformis I understand has no salesmen. They like a lot of device comoanies rely on contract folks. No benefits and all commission. Eventually when the hospitals and docs get signed up the reps get small commissions, but they are hungry. I think it will be different with Mayo as we have a deal with them.
I love these guys..They project. I guess they figure the 13 centers will do 20 procedures each the remainder of 2015. Those guys could not hit water if they fell out of a boat. Inventory??? what are you looking at Pharma? Divide 1 million by $600. That is 1600 devices. I guess the cost at $600 and it may be lower. The operations guy hopefully has it figured out. The chain of delivery is easy and I am sure they can meet any demand. Forward guidance? Nice but I think they are going to be on a learning curve like us. We know a few variables. Bariatric surgeries which eh analysts think we will get zero. The number of obese people worldwide. The number of doctors and hospitals. That data add up to 253 procedures to you????
Excuses??? They have not made excuses. The have said NOTHING!!!!!! I agree with you. Let ius see a viable game plan with some forward guidance.
No argument. Greg Lea seems the smartest of the group. Knudson has a great track record but I have concluded their game plans keep shifting and there are so many things we would like to know. International? Domestic hospitals? Manufacture? Collaborations? Patent infringement?
Miniaturized devices? Webinair? How big are the inquiries? Price of the device? Reimbursement discussions? Mayo collaboration? I could add others, but this is going to be an exciting time. The market for small caps sucks and ETRM is now in a position where they have to show the market the product is as good as we think. The market it seems as of now to say prove it. Anyway, I want to hear more than corporate platitudes and smoke.